Avai Bio (AVAI) Return on Capital Employed (2019 - 2026)

Avai Bio (AVAI) has 8 years of Return on Capital Employed data on file, last reported at 58.03% in Q1 2026.

• For the quarter ending Q1 2026, Return on Capital Employed fell 8056.0% year-over-year to 58.03%; the trailing twelve-month figure through Mar 2026 stood at 58.03% (down 8056.0% YoY), and the FY2026 full-year result was 58.53%, down 1685.0% from the prior year.
• Return on Capital Employed retreated to 58.03% in Q1 2026, from 153.43% in the prior quarter.
• In the past five years, Return on Capital Employed ranged from a high of 159.76% in Q4 2024 to a low of 135.74% in Q2 2022.
• A 5-year average of 47.75% and a median of 58.03% in 2026 frame the typical range for Return on Capital Employed.
• Across the five-year window, Return on Capital Employed slumped 93246 bps in 2022 and jumped 24832 bps in 2024, its largest moves.
• Tracing AVAI's Return on Capital Employed over 5 years: stood at 45.1% in 2022, then tumbled by 96 bps to 88.55% in 2023, then jumped by 280 bps to 159.76% in 2024, then declined by 4 bps to 153.43% in 2025, then tumbled by 62 bps to 58.03% in 2026.
• Business Quant data shows AVAI's Return on Capital Employed at 58.03% in Q1 2026, 153.43% in Q4 2025, and 138.09% in Q3 2025.